Casein kinase II is a selective target of HIV-1 transcriptional inhibitors.

The identification of cellular factors that are required to complete various steps of the HIV-1 life cycle may lead to the development of new therapeutics. One key step, transcription from the integrated provirus, is inhibited by members of two distinct classes of compounds, the flavonoids and the benzothiophenes, via an unknown mechanism, possibly involving a cellular factor. A marked specificity toward inhibiting HIV-1 transcription is evidenced by the ability of drug-treated cells to retain their proliferative and differentiation capabilities. In addition, the compounds do not impede the activation and function of the transcriptional factor NF-kappaB. Here we report on the identification of several cellular proteins that mediate the HIV-1 transcriptional inhibitory property of the flavonoid chrysin. Chemical and immunologic analyses identified these cellular proteins as the individual subunits of casein kinase II (CKII). Though structurally unrelated to chrysin, an HIV-1 inhibitory benzothiophene also bound selectively to CKII. Both chrysin and the benzothiophenes inhibited human recombinant CKII enzymatic activity and showed competitive kinetics with respect to ATP, analogous to the classic CKII inhibitor 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB). Moreover, DRB potently inhibited HIV-1 expression in chronically infected cells. CKII may regulate HIV-1 transcription by phosphorylating cellular proteins involved in HIV-1 transactivation that contain multiple CKII phosphorylation consensus sequences.

[1]  D. Schomburg,et al.  Synthesis and characterization of the hydrophilic C-terminal domain of the human immunodeficiency virus type 1-encoded virus protein U (Vpu). , 1993, Peptide research.

[2]  E. Wingender,et al.  The Human Immunodeficiency Virus Type 1 Encoded Vpu Protein is Phosphorylated by Casein Kinase-2 (CK-2) at Positions Ser52 and Ser56 within a Predicted α-Helix-Turn-α-Helix-Motif , 1994 .

[3]  S. Barik,et al.  Phosphorylation of Ser232 directly regulates the transcriptional activity of the P protein of human respiratory syncytial virus: phosphorylation of Ser237 may play an accessory role. , 1995, Virology.

[4]  Anthony S. Fauci,et al.  Host factors and the pathogenesis of HIV-induced disease , 1996, Nature.

[5]  J. Hiscott,et al.  Phosphorylation of IkappaBalpha in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability , 1996, Molecular and cellular biology.

[6]  M. Braddock,et al.  Blocking of Tat-dependent HIV-1 RNA modification by an inhibitor of RNA polymerase II processivity , 1991, Nature.

[7]  I. Verma,et al.  Constitutive phosphorylation of IkappaBalpha by casein kinase II occurs preferentially at serine 293: requirement for degradation of free IkappaBalpha , 1996, Molecular and cellular biology.

[8]  A. Banerjee,et al.  Involvement of cellular casein kinase II in the phosphorylation of measles virus P protein: identification of phosphorylation sites. , 1995, Virology.

[9]  J N Weinstein,et al.  Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication. , 1994, Science.

[10]  David Baltimore,et al.  NF-κB: Ten Years After , 1996, Cell.

[11]  H. Weiner,et al.  Purification of liver aldehyde dehydrogenase by p-hydroxyacetophenone-sepharose affinity matrix and the coelution of chloramphenicol acetyl transferase from the same matrix with recombinantly expressed aldehyde dehydrogenase. , 1992, Protein expression and purification.

[12]  P. Sharp,et al.  HIV‐1 Tat protein promotes formation of more‐processive elongation complexes. , 1991, The EMBO journal.

[13]  T. Folks,et al.  Inhibition of HIV activation in latently infected cells by flavonoid compounds. , 1996, AIDS research and human retroviruses.

[14]  C. Allende,et al.  Protein kinase CK2: an enzyme with multiple substrates and a puzzling regulation , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  A. Rice,et al.  The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function , 1996, Journal of virology.

[16]  E. Krebs,et al.  Phosphorylation of the beta subunit of casein kinase II in human A431 cells. Identification of the autophosphorylation site and a site phosphorylated by p34cdc2. , 1991, The Journal of biological chemistry.

[17]  D. Marshak,et al.  Synthetic peptide substrates for casein kinase II. , 1991, Methods in enzymology.

[18]  S. Barik,et al.  Phosphorylation of specific serine residues within the acidic domain of the phosphoprotein of vesicular stomatitis virus regulates transcription in vitro , 1992, Journal of virology.

[19]  D. Shugar.  Development of inhibitors of protein kinases CKI and CKII and some related aspects, including donor and acceptor specificities and viral protein kinases. , 1994, Cellular & molecular biology research.

[20]  R. Zandomeni.  Kinetics of inhibition by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole on calf thymus casein kinase II. , 1989, The Biochemical journal.

[21]  A. Brunati,et al.  Altered protein kinase activities of lymphoid cells transformed by Abelson and Moloney leukemia viruses , 1986, FEBS letters.

[22]  W. Haseltine,et al.  Functional analysis of the phosphorylation sites on the human immunodeficiency virus type 1 Vpu protein. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[23]  Yuan Gao,et al.  Multimerization and transcriptional activation of the phosphoprotein (P) of vesicular stomatitis virus by casein kinase‐II. , 1995, The EMBO journal.

[24]  L. Pinna,et al.  A historical view of protein kinase CK2. , 1994, Cellular & molecular biology research.

[25]  R. Gaynor,et al.  The cellular factor TRP‐185 regulates RNA polymerase II binding to HIV‐1 TAR RNA. , 1995, The EMBO journal.

[26]  S. Barik,et al.  Phosphorylation by cellular casein kinase II is essential for transcriptional activity of vesicular stomatitis virus phosphoprotein P. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[27]  S. Gracheck,et al.  Compounds That Target Novel Cellular Components Involved in HIV-1 Transcription , 1995, Molecular medicine.

[28]  P. Janosch,et al.  Characterization of IkappaB kinases. IkappaB-alpha is not phosphorylated by Raf-1 or protein kinase C isozymes, but is a casein kinase II substrate. , 1996, The Journal of biological chemistry.

[29]  R. Gaynor,et al.  Identification of a Group of Cellular Cofactors That Stimulate the Binding of RNA Polymerase II and TRP-185 to Human Immunodeficiency Virus 1 TAR RNA (*) , 1996, The Journal of Biological Chemistry.

[30]  G. Bren,et al.  Casein kinase II phosphorylates I kappa B alpha at S-283, S-289, S-293, and T-291 and is required for its degradation , 1996, Molecular and cellular biology.

[31]  M. A. Jabbar,et al.  The human immunodeficiency virus type 1 Vpu protein tethered to the CD4 extracellular domain is localized to the plasma membrane and is biologically active in the secretory pathway of mammalian cells: implications for the mechanisms of Vpu function. , 1996, Virology.

[32]  U. Schubert,et al.  Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments , 1994, Journal of virology.

[33]  G. Schochetman,et al.  A human chromosome 12-associated 83-kilodalton cellular protein specifically binds to the loop region of human immunodeficiency virus type 1 trans-activation response element RNA , 1995, Journal of virology.

[34]  D. Pappin,et al.  Identification of myocardial proteins from two‐dimensional gels by peptide mass fingerprinting , 1995, Electrophoresis.

[35]  D. Boschelli,et al.  3-Alkoxybenzo[b]thiophene-2-carboxamides as inhibitors of neutrophil-endothelial cell adhesion. , 1994, Journal of medicinal chemistry.

[36]  R. Desrosiers,et al.  Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes. , 1994, AIDS research and human retroviruses.

[37]  G. Pauli,et al.  Human-immundeficiency-virus-type-1-encoded Vpu protein is phosphorylated by casein kinase II , 1992 .

[38]  G. Nabel,et al.  Oscillation of the human immunodeficiency virus surface receptor is regulated by the state of viral activation in a CD4+ cell model of chronic infection , 1991, Journal of virology.

[39]  G. Hathaway,et al.  Inhibition of casein kinase II by heparin. , 1980, The Journal of biological chemistry.

[40]  C. Rosen,et al.  Tat and Rev: positive regulators of HIV gene expression. , 1990, AIDS.

[41]  I. Verma,et al.  Constitutive phosphorylation of I kappa B alpha by casein kinase II. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[42]  D. Litchfield,et al.  Biosynthesis of casein kinase II in lymphoid cell lines. , 1994, European journal of biochemistry.